Home > Insider Trading > Filing (0001455244-10-000026)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1278129	Osteologix Inc.	OLGX OB	Pharmaceutical Preparations (2834)	320104570

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1360542	K/S Biotech Nordic	Ostergade 5, 3Rd Floor, Dk-1100 Copenhagen K G7	No	No	Yes	No
1432652	K/S Fund Opportunity Biotech Nordic	Ostergade 5, 3Rd Floor, Dk-1100 Copenhagen K G7	No	No	Yes	No
1432680	Aps Partner General Biotech Nordic	Ostergade 5, 3Rd Floor, Dk-1100 Copenhagen K G7	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2010-01-07	1,992,428	$0.50	5,022,732	No	4	P	Indirect	By Nordic Biotech Opportunity Fund K/S

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Nordic Biotech Opportunity Fund K/S

Footnotes

The price was misstated on the Reporting Person's original Form 4 filed January 11, 2010 and has been corrected in this amendment.
Nordic Biotech General Partner ApS is the managing partner of Nordic Biotech Opportunity Fund K/S. Nordic Biotech General Partner ApS hereby disclaims any beneficial ownership of the securities held directly by Nordic Biotech Opportunity Fund K/S for purposes of Section 16 of the Act, except to the extent of its indirect pecuniary interest therein.